Press release
Global Therapeutic Vaccines Market is Anticipated to Reach USD 11,880.8 Million and Growing at a CAGR of 13.55% During Forecast Period 2023 - 2030
Infinium Global Research presents a comprehensive report elucidating the nuances of the Global Therapeutic Vaccines Market, featuring in-depth analyses of its segments and sub-segments, encompassing the driving forces, limitations, and macro indicators influencing both short-term and long-term market trends. The report offers a detailed portrayal of trends, forecasts, and monetary valuations within the global therapeutic vaccines market, projecting a robust Compound Annual Growth Rate (CAGR) of 13.55% for the period between 2023 and 2030.To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/reports/sample-request/1486
Market Insights and Functionalities
Unlike preventive vaccines, therapeutic vaccines serve as a treatment method, stimulating the immune system to target infections or specific diseased cells, such as cancer cells. They are integral in managing complications associated with chronic diseases, including pneumococcal disease, DTP, influenza, human papillomavirus, meningococcal disease, polio, hepatitis, varicella, and dengue. Notably, the U.S. Food and Drug Administration recently approved the first therapeutic cancer vaccine, signaling a pivotal milestone in medical advancements.
Market Drivers and Growth Factors
The burgeoning occurrence of cancer, cardiovascular diseases, HIV infections, and diverse chronic ailments significantly fuels the therapeutic vaccines market. Heightened governmental funding for vaccine development and increased public awareness regarding severe diseases are pivotal factors propelling market growth. However, the substantial treatment costs pose a potential hindrance. Concurrently, extensive Research and development activities by pharmaceutical entities aimed at developing novel vaccines present promising growth opportunities in the therapeutic vaccines market.
Geographical and Segmental Overview
North America, led by the United States, remains a dominant force in the therapeutic vaccines market, leveraging its advanced medical infrastructure and escalated research funding. Conversely, the Asia-Pacific region is poised for rapid growth, driven by increasing disease prevalence, rising disposable incomes, and a burgeoning elderly population.
Segmentation and Market Players
The report segments the global therapeutic vaccines market based on vaccines types, disease indications, administration methods, and end-users. Key players such as Pfizer, Inc., GlaxoSmithKline PLC., Merck & Co., Inc., and Sanofi Pasteur SA drive the industry, actively contributing to therapeutic vaccine innovations and market dynamics.
Enquire Here Get Customization & Check the Discount for the Report @ https://www.infiniumglobalresearch.com/reports/customization/1486
Table of Content
Chapter 1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
Chapter 2. Executive Summary
2.1. Therapeutic Vaccines Market Highlights
2.2. Therapeutic Vaccines Market Projection
2.3. Therapeutic Vaccines Market Regional Highlights
Chapter 3. Global Therapeutic Vaccines Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Vaccines Type
3.4.2. IGR-Growth Matrix Analysis by Disease Indication
3.4.3. IGR-Growth Matrix Analysis by Region
3.5. Value Chain Therapeutic Vaccines Market
Chapter 4. Therapeutic Vaccines Market Macro Indicator Analysis
Chapter 5. Global Therapeutic Vaccines Market by Vaccines Type
5.1. Auto Immune Diseases Vaccines
5.2. Neurological Disease Vaccines
5.3. Chronic Disease Vaccines
5.4. Infectious Diseases Vaccines
Chapter 6. Global Therapeutic Vaccines Market by Disease Indication
6.1. Pneumococcal Disease
6.2. DTP
6.3. Influenza
6.4. Human Papilloma Virus
6.5. Meningococcal Disease
6.6. Polio
6.7. Hepatitis
6.8. MMR
6.9. Varicella
6.10. Dengue
6.11. Other Disease Indications
Chapter 7. Global Therapeutic Vaccines Market by Administration
7.1. Intramuscular and Subcutaneous Administration
7.2. Oral Administration
7.3. Other Routes of Administration
Chapter 8. Global Therapeutic Vaccines Market by End User
8.1. Pediatrics
8.2. Adults
Chapter 9. Global Therapeutic Vaccines Market by Region 2023-2030
9.1. North America
9.1.1. North America Therapeutic Vaccines Market by Vaccines Type
9.1.2. North America Therapeutic Vaccines Market by Disease Indication
9.1.3. North America Therapeutic Vaccines Market by Administration
9.1.4. North America Therapeutic Vaccines Market by End User
9.1.5. North America Therapeutic Vaccines Market by Country
9.2. Europe
9.2.1. Europe Therapeutic Vaccines Market by Vaccines Type
9.2.2. Europe Therapeutic Vaccines Market by Disease Indication
9.2.3. North America Therapeutic Vaccines Market by Administration
9.2.4. North America Therapeutic Vaccines Market by End User
9.2.5. Europe Therapeutic Vaccines Market by Country
9.3. Asia-Pacific
9.3.1. Asia-Pacific Therapeutic Vaccines Market by Vaccines Type
9.3.2. Asia-Pacific Therapeutic Vaccines Market by Disease Indication
9.3.3. North America Therapeutic Vaccines Market by Administration
9.3.4. North America Therapeutic Vaccines Market by End User
9.3.5. Asia-Pacific Therapeutic Vaccines Market by Country
9.4. RoW
9.4.1. RoW Therapeutic Vaccines Market by Vaccines Type
9.4.2. North America Therapeutic Vaccines Market by Disease Indication
9.4.3. North America Therapeutic Vaccines Market by Administration
9.4.4. RoW Therapeutic Vaccines Market by End User
9.4.5. RoW Therapeutic Vaccines Market by Sub-region
More Insights on this report, Speak to Our Analyst: https://www.infiniumglobalresearch.com/reports/enquiry/1486
Reasons to Buy this Report:
=> Comprehensive analysis of global as well as regional markets of Therapeutic Vaccines.
=> Complete coverage of all the product types and application segments to analyze the trends, developments, and forecast of market size up to 2030.
=> Comprehensive analysis of the companies operating in this market. The company profile includes an analysis of the product portfolio, revenue, SWOT analysis, and the latest developments of the company.
=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus on to invest, consolidate, expand, and/or diversify.
2nd Floor, Ganadish Empire, Rahatani Chowk, Pimple Saudagar, Pimpri-Chinchwad, Maharashtra 411027
About Infinium Global Research:
Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes, and non-profit/non-government organizations to meet their knowledge and information needs.
Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations, and the environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Therapeutic Vaccines Market is Anticipated to Reach USD 11,880.8 Million and Growing at a CAGR of 13.55% During Forecast Period 2023 - 2030 here
News-ID: 3298151 • Views: …
More Releases from Infinium Global Research LLP

Infinium Global Research LLP Launches Comprehensive Service to Assist Foreign Co …
Pune, India - October 26, 2024 - Infinium Global Research LLP is excited to announce the launch of a dedicated service aimed at providing end-to-end support for foreign companies entering or expanding within the Indian market. With a strategic network of partnerships with top legal and consulting firms and increased presence across key Indian cities, Infinium is well-equipped to facilitate smooth market entry, operational setup, and business expansion for international…

Global Sterilization Services Market Size Worth USD 12.55 Billion By 2030 | CAGR …
Infinium Global Research, a leading provider of market intelligence, has recently launched an in-depth report on the Global Sterilization Services Market, offering comprehensive analysis and detailed insights into its segments and market trends.
The comprehensive study explores the impact of various factors such as drivers, restraints, and macro indicators on both the global and regional sterilization services market, providing crucial forecasts and dollar value projections.
To Know More Request a Sample of…

Global Proprotein Convertase Subtilisin/Kexin Type 9 Market is Projected to Surp …
Infinium Global Research introduces a detailed analysis of the global and regional Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) market, providing an extensive study of its segments, trends, forecasts, and dollar values in their latest report. This comprehensive study empowers stakeholders in the pharmaceutical and healthcare sectors with invaluable insights into this burgeoning market.
To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/420
Market Insight:
The global Proprotein Convertase Subtilisin/Kexin Type 9 market,…

Global Neuromodulation Market is Anticipated to Reach USD 7.27 Billion and Growi …
Infinium Global Research, a pioneering market intelligence firm, introduces a comprehensive report delving into the Global Neuromodulation Market, providing extensive analysis and in-depth exploration of its segments, market trends, and projections.
To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/93
Market Insight:
The global neuromodulation market, valued at USD 3.51 Billion in 2022, is poised to ascend to USD 7.27 Billion by 2030, exhibiting a noteworthy CAGR of 9.59% during the forecast…
More Releases for Vaccines
Vaccines Market: Information by Type (Monovalent Vaccines, Multivalent Vaccines) …
Till date, vaccines have majorly contributed to eradicating several severe diseases—smallpox and polio—from the face of the earth. During 1980–90, around millions of people died due to smallpox. Moreover, after the introduction of a worldwide End Polio Campaign, the number of polio cases has reduced to 407 in 2013 from 350,000 in 1988, the CDC.
Global vaccines market was valued at USD 30.2 billion in 2018 and is expected to…
Global Pet Vaccine Market By Type (Attenuated Live Vaccines, Conjugate Vaccines, …
The Global Pet Vaccine Market 2020 report implement in-depth research of the industry with a focus on the current market trends future prospects. The Global Pet Vaccine Market report aims to provide an overview of Pet Vaccine Market players with detailed market segmentation by product, application and geographical region. It also provides market share and size, revenue forecast, growth opportunity. The most recent trending report Worldwide Pet Vaccine Market Economy…
Animal Vaccines Market Report 2018: Segmentation by Product (Attenuated Vaccines …
Global Animal Vaccines market research report provides company profile for Merck & Co., Inc., Zoetis Inc., Ceva Sant Animale, Sanofi S.A., Romvac, Vaxxinova, Biovac, Merial, Anicon Labor GmbH, Nexvet, PHL Associates, Inc., Hygieia Biological Laboratories, Colorado Serum Company, Pfizer, Arko Laboratories, Ltd. Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in…
Vaccines & Vaccination Market Report 2018: Segmentation by Type (Subunit vaccine …
Global Vaccines & Vaccination market research report provides company profile for CSL, Emergent BioSolutions, GSK, Johnson & Johnson, Pfizer, Merck, Sanofi, Abbott, AstraZeneca, Bavarian Nordic, Novartis, Bharat Biotech, Bio-Med and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year…
Global Veterinary Vaccines Market, By Technology Type (Inactivated Vaccines, Tox …
Veterinary/Animal Vaccines – Ensure good health of human’s best friends
Veterinary vaccination enhances the health of animals, thus improving their life expectancies. Most common veterinary vaccines include those for rabies, E. coli, distemper, hepatitis rotavirus, parvovirus, brucellosis, and pinkeye. Various diseases such as foot-and-mouth disease and influenza adversely affect livestock across the globe. Economic losses due to death of livestock is significant as it impacts the supply of dairy products, meat,…
Global Veterinary Vaccines Market, By Technology Type (Inactivated Vaccines, Tox …
Veterinary/Animal Vaccines – Ensure good health of human’s best friends
Veterinary vaccination enhances the health of animals, thus improving their life expectancies. Most common veterinary vaccines include those for rabies, E. coli, distemper, hepatitis rotavirus, parvovirus, brucellosis, and pinkeye. Various diseases such as foot-and-mouth disease and influenza adversely affect livestock across the globe. Economic losses due to death of livestock is significant as it impacts the supply of dairy products, meat,…